Variation in clinical presentation, complications and outcomes for Māori and Pacific peoples among hospitalised adults with COVID‐19 in 2022, Aotearoa New Zealand
Open Access
- 21 June 2025
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (8) , 1339-1349
Abstract
Background: Pacific region‐specific data on the clinical course of COVID‐19 are limited. We aimed to describe clinical features and outcomes from Aotearoa New Zealand patients, focusing on Māori and Pacific peoples.Methods: We conducted a retrospective cohort study among adults (≥16 years) hospitalised due to COVID‐19 at 11 hospitals from January to May 2022. We included all Māori and Pacific patients and every second non‐Māori, non‐Pacific (NMNP) patient using data from chart review and national datasets.Results: Of 2319 patients, 582 (25%) were Māori, 914 (39%) Pacific peoples and 862 NMNP (median age 52, 57 and 63 years respectively). Vaccination coverage (≥2 doses) was 73.4% (n = 437) for Māori, 76.7% (n = 701) for Pacific peoples (n = 701) and 84.8% (n = 731) for NMNP. Among 832 (35.9%) with complications, Māori had a greater risk than NMNP of acute kidney injury (risk ratio (RR) 1.87, P < 0.001), cardiac arrhythmia (RR = 1.60, P = 0.023), shock (RR = 2.64, P = 0.005), myocardial infarction (RR 2.21, P = 0.042), cardiac arrest (RR 2.68, P = 0.046) and acute respiratory distress syndrome (RR = 2.81, P = 0.008). Pacific patients experienced a greater risk than NMNP of acute kidney injury (RR = 2.18, P < 0.001) and pneumonia (RR = 1.32, P = 0.047) and a lower risk of thromboembolism (RR = 0.35, P = 0.004) and myocarditis/pericarditis (RR = 0.23, P = 0.003). During admission, 23 (3.3%) Māori, 36 (3.9%) Pacific and 28 (3.2%) NMNP patients died, with no difference in age‐standardised mortality.Conclusions: The clinical course of patients hospitalised by COVID‐19 varied between ethnic groups, likely reflecting differential access to social determinants of health. Healthcare services that respond to this variability are needed to achieve the highest attainable health for all.Keywords
Funding Information
- Ministry of Health, New Zealand
This publication has 20 references indexed in Scilit:
- The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling studyVaccine, 2024
- Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variantsThe Lancet Microbe, 2023
- The evolution of SARS-CoV-2Nature Reviews Microbiology, 2023
- Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19International Journal of Epidemiology, 2023
- Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africaInternational Journal of Infectious Diseases, 2021
- Understanding vulnerability to COVID‐19 in New Zealand: a nationwide cross‐sectional studyJournal of the Royal Society of New Zealand, 2021
- Evidence mounts on the disproportionate effect of COVID-19 on ethnic minoritiesThe Lancet Respiratory Medicine, 2020
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyBMJ, 2020
- Invited Commentary: "Race," Racism, and the Practice of EpidemiologyAmerican Journal of Epidemiology, 2001
- CONFIDENCE INTERVALS FOR DIRECTLY STANDARDIZED RATES: A METHOD BASED ON THE GAMMA DISTRIBUTIONStatistics in Medicine, 1997